Aurisco Pharmaceutical Co., Ltd. (SH.605116), established in 1998, is an innovative and international pharmaceutical company specializing in the R&D, production, and sales of specialized complex APIs and finished dosage forms. The company operates with its headquarters in Shanghai, featuring four production facilities and five R&D centers, along with sales branches in the United States, Europe, India, and South America.

With over two decades of deep commitment in the pharmaceutical industry, Aurisco continuously drives technological innovation and has achieved a leading position in China in areas such as complex synthesis, synthetic biology, and photochemistry. The company has established long-term partnerships with renowned global pharmaceutical enterprises.

Supported by a robust quality and EHS management system, sufficient production capacity, and a global sales network, Aurisco provides high-quality products and efficient services to customers worldwide.